StockIQ.techLENZ Therapeutics, Inc. (LENZ) Stock Analysis
Free AI-powered analysis and research for LENZ Therapeutics, Inc. stock
Sector: Healthcare
Full LENZ report
LENZ Therapeutics, Inc. (LENZ) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze LENZ Now →📰 Latest Update
LENZ (LENZ) Q3 2026 Earnings Call Transcript
Mon, November 2, 2026 at 7:17 PM UTC 4 min read
LENZ Therapeutics reported a revenue of $2.6 million for Q3 2026, with telehealth contributing to over 50% of new prescriptions. The company experienced more than 50% growth in both product revenue and total prescriptions, driven by consumer demand initiatives and a strategic reorganization to focus on a consumer-led commercial model. As part of this transition, LENZ plans to reduce its workforce to approximately 40 employees and decrease overall operating expenses by more than 50%.